Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
gptkb:antimuscarinic_agent |
| gptkbp:ATCCode |
gptkb:A03AB12
|
| gptkbp:CASNumber |
gptkb:62-13-5
|
| gptkbp:contraindication |
gptkb:myasthenia_gravis
gptkb:glaucoma obstructive uropathy |
| gptkbp:eliminationHalfLife |
1.5 hours
|
| gptkbp:hasMolecularFormula |
C21H26BrNO3
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
muscarinic acetylcholine receptor antagonist
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
constipation
blurred vision dry mouth urinary retention |
| gptkbp:synonym |
gptkb:mepenzolate
|
| gptkbp:usedFor |
gptkb:peptic_ulcer_disease
gastrointestinal disorders |
| gptkbp:bfsParent |
gptkb:Cantil
|
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
mepenzolate bromide
|